MediXall Group, Inc. (MDXL)
OTCMKTS
· Delayed Price · Currency is USD
0.0035
0.00 (0.00%)
At close: Jan 28, 2025
MediXall Group Statistics
Total Valuation
MediXall Group has a market cap or net worth of 732,032. The enterprise value is 4.56 million.
Market Cap | 732,032 |
Enterprise Value | 4.56M |
Important Dates
The next estimated earnings date is Thursday, April 17, 2025.
Earnings Date | Apr 17, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
MediXall Group has 209.15 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 209.15M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +0.03% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.44 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -0.93 |
EV / Sales | 14.72 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.00
Current Ratio | 0.00 |
Quick Ratio | 0.00 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -6.05 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -460.46% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 60.03% |
Revenue Per Employee | 18,201 |
Profits Per Employee | -286,871 |
Employee Count | 17 |
Asset Turnover | 0.58 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | 32.59 |
52-Week Price Change | n/a |
50-Day Moving Average | 0.35 |
200-Day Moving Average | 1.10 |
Relative Strength Index (RSI) | 41.05 |
Average Volume (20 Days) | 13,031 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MediXall Group had revenue of 309,422 and -4.88 million in losses. Loss per share was -0.04.
Revenue | 309,422 |
Gross Profit | -932,300 |
Operating Income | -3.92M |
Pretax Income | -4.56M |
Net Income | -4.88M |
EBITDA | -3.88M |
EBIT | -3.92M |
Loss Per Share | -0.04 |
Balance Sheet
The company has 10,721 in cash and 3.83 million in debt, giving a net cash position of -3.82 million or -0.02 per share.
Cash & Cash Equivalents | 10,721 |
Total Debt | 3.83M |
Net Cash | -3.82M |
Net Cash Per Share | -0.02 |
Equity (Book Value) | -6.52M |
Book Value Per Share | -0.05 |
Working Capital | -6.71M |
Cash Flow
Operating Cash Flow | -1.23M |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | -1,265.64% |
Pretax Margin | -1,474.82% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MediXall Group does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.00% |
Shareholder Yield | -9.00% |
Earnings Yield | -666.20% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |